ライフサイエンスコーパス: perihilar

1 Enlargement of perihilar (adjusted odds ratio [aOR]: 6.6; 95% confidenc

2 analysis of a large number of intrahepatic, perihilar and distal cholangiocarcinomas and gallbladder

3 em, which can be classified as intrahepatic, perihilar and distal.

4 lar ground-glass opacification, and systemic perihilar and intercostal vessels.

5 erate inter-reader agreement, enlargement of perihilar and/or paratracheal lymph nodes, bronchial dev

6 tudy, 2395 CCA cases (1169 intrahepatic, 995 perihilar, and 231 distal) seen at the Mayo Clinic, Roch

7 nts, 44 (8%) had intrahepatic, 281 (50%) had perihilar, and 239 (42%) had distal tumors.

8 into three broad groups: 1) intrahepatic, 2) perihilar, and 3) distal tumors.

9 oma, 18 (6%) had intrahepatic, 196 (67%) had perihilar, and 80 (27%) had distal tumors.

10 rise a mucin-secreting form, intrahepatic or perihilar, and a mixed form located peripherally.

11 nd 0.29 (95% CI 0.19-0.44) for intrahepatic, perihilar, and distal CCA, respectively (P < 0.001 for a

12 %), 124 (79%), and 9 (6%) with intrahepatic, perihilar, and distal CCA, respectively.

13 %), 124 (79%), and 9 (6%) with intrahepatic, perihilar, and distal CCA, respectively.

14 liary tract cancers, including intrahepatic, perihilar, and distal cholangiocarcinoma as well as gall

15 Patients were divided into intrahepatic, perihilar, and distal groups.

16 ar survival rates for resected intrahepatic, perihilar, and distal tumors were 44%, 11%, and 28%, and

17 dian survivals for R0-resected intrahepatic, perihilar, and distal tumors were 80, 30, and 25 months,

18 ifferent anatomical locations (intrahepatic, perihilar, and distal).

19 y tree, CCAs are classified as intrahepatic, perihilar, and distal, and these subtypes are now consid

20 with distal (AOR = 4.2, 95% CI 2.5-7.0) than perihilar (AOR = 2.9, 95% CI 2.2-3.8) or intrahepatic (A

21 holangitis was more strongly associated with perihilar (AOR = 453, 95% CI 104-999) than intrahepatic

22 Histomorphological analysis of perihilar bile ducts was performed to assess differences

23 a curative option for selected patients with perihilar but not with intrahepatic or distal cholangioc

24 ied anatomically as intrahepatic CCA (iCCA), perihilar CCA (pCCA), or distal CCA.

25 terize MAIT cells in intrahepatic (iCCA) and perihilar CCA (pCCA).

26 tion of DCLK1 in intrahepatic CCA (iCCA) and perihilar CCA (pCCA).

27 curative-intent surgery for intrahepatic and perihilar CCA excluding individuals with neoadjuvant the

28 chemoradiation and liver transplantation for perihilar CCA is excellent.

29 vidence regarding its safety and efficacy in perihilar CCA remains limited.

30 We reviewed all patients with unresectable perihilar CCA treated with neoadjuvant chemoradiation in

31 n 5-year overall survival (OS) were found in perihilar CCA versus intrahepatic (i) CCA, and in small

32 Patients with unresectable perihilar CCA were prospectively randomized into 2 group

33 is was associated with both intrahepatic and perihilar CCA, with similar AORs of 14.

34 AS allelic variants were highly prevalent in perihilar cholangiocarcinoma (28.6%) and extrahepatic ch

35 Early detection of perihilar cholangiocarcinoma (CCA) among patients with p

36 ation for selected patients with early-stage perihilar cholangiocarcinoma (CCA) following neoadjuvant

37 ahepatic cholangiocarcinoma (ECC), including perihilar cholangiocarcinoma (pCCA) and distal cholangio

38 e with primary sclerosing cholangitis (PSC), perihilar cholangiocarcinoma (pCCA) is often diagnosed a

39 is the principal treatment for unresectable perihilar cholangiocarcinoma (pCCA) patients with jaundi

40 The optimal treatment strategy for de novo perihilar cholangiocarcinoma (pCCA) remains debated.

41 Liver surgery in perihilar cholangiocarcinoma (PHC) is associated with hi

42 Importance: Resection of perihilar cholangiocarcinoma (PHC) is high-risk surgery,

43 Perihilar cholangiocarcinoma (PHCCA) is the most common

44 cations (intrahepatic cholangiocarcinoma and perihilar cholangiocarcinoma [phCC]) and liver metastase

45 on can be curative in selected patients with perihilar cholangiocarcinoma after neoadjuvant chemoradi

46 lterations in patients with BTCs, especially perihilar cholangiocarcinoma and extrahepatic cholangioc

47 Trans-papillary biliary drainage for perihilar cholangiocarcinoma carries a risk of cholangit

48 n and liver transplantation for unresectable perihilar cholangiocarcinoma caused the United Network o

49 Consecutive patients with a diagnosis of perihilar cholangiocarcinoma presenting between January

50 Clinical and imaging findings of perihilar cholangiocarcinoma should prompt evaluation at

51 e recurrence, defining a "futile" outcome in perihilar cholangiocarcinoma surgery.

52 pective study included patients with de novo perihilar cholangiocarcinoma treated at the Mayo Clinic

53 nts (69%) presenting with a new diagnosis of perihilar cholangiocarcinoma underwent trans-papillary b

54 criteria of treating 3 or more patients with perihilar cholangiocarcinoma using neoadjuvant therapy,

55 utcome of previously untreated patients with perihilar cholangiocarcinoma who present to a cancer ref

56 Patients with perihilar cholangiocarcinoma who were treated with neoad

57 ment of biliary obstruction is obligatory in perihilar cholangiocarcinoma, and advanced cytological t

58 section remains the only curative option for perihilar cholangiocarcinoma, it is well known that such

59 ocellular carcinoma and select patients with perihilar cholangiocarcinoma, transplant has been increa

60 ected to undergo a major liver resection for perihilar cholangiocarcinoma.

61 l outcomes in selected patients with de novo perihilar cholangiocarcinoma.

62 nchmark values for the surgical treatment of perihilar cholangiocarcinomas (PHC) to enable unbiased c

63 Ninety-three percent (25 of 27) of perihilar CRLM treated with IRE were at least partially

64 ed with shorter survival among patients with perihilar/distal CCA.

65 septal lines, which was mild with apical and perihilar distribution in 12 subjects, severe and diffus

66 present the global concept for performing a perihilar Glissonian approach and its application to eac

67 Perihilar Glissonian approach is a safe and reproducible

68 from the liver surface, respectively, and as perihilar if the tumor margins extend to within 1 cm fro

69 tient who developed peripheral eosinophilia, perihilar infiltrates, and hypoxemia after autologous st

70 evealed collapsing lesions of FSGS, four had perihilar lesions, and seven showed > or =40% tubular at

71 stigated for intrathoracic TB enlargement of perihilar or paratracheal lymph nodes, bronchial compres

72 with the rest being extrahepatic (including perihilar [pCCA] and distal CCA).

73 s were attributable to damage to central and perihilar structures and correlated with dose to the pro

74 ate radiation toxicity involving central and perihilar structures.

75 similar between mucin-intrahepatic and mucin-perihilar subtypes, CD13(+) CSCs characterized mixed-int